ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients
Cancer Gene Therapy
◽
10.1038/sj.cgt.7700600
◽
2003
◽
Vol 10
(7)
◽
pp. 509-517
◽
Cited By ~ 33
Author(s):
Anand G Menon
◽
Peter J K Kuppen
◽
Sjoerd H van der Burg
◽
Rienk Offringa
◽
Marie Claude Bonnet
◽
...
Keyword(s):
Colorectal Cancer
◽
Cancer Patients
◽
Intravenous Administration
◽
P53 Gene
◽
Wild Type
◽
Wild Type P53
◽
Colorectal Cancer Patients
◽
Canarypox Virus
◽
Human Wild Type
Download Full-text
Related Documents
Cited By
References
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild type colorectal cancer patients receiving irinotecan/cetuximab
Annals of Oncology
◽
10.1093/annonc/mdx422.021
◽
2017
◽
Vol 28
◽
pp. vi9-vi10
Author(s):
M. Puzzoni
◽
L. Demurtas
◽
R. Giampieri
◽
P. Ziranu
◽
V. Pusceddu
◽
...
Keyword(s):
Colorectal Cancer
◽
Cancer Patients
◽
Copy Number
◽
Primary Tumour
◽
Gene Copy Number
◽
Gene Copy
◽
Wild Type
◽
Egfr Gene
◽
Colorectal Cancer Patients
Download Full-text
Correlation between malignancy grade and p53 gene in relation to thymidine phosphorylase activity in colorectal cancer patients
Oncology Reports
◽
10.3892/or.9.6.1267
◽
2002
◽
Author(s):
Tatsuya Aoki
◽
Kenji Katsumata
◽
Akihiko Tsuchida
◽
Hidenori Tomioka
◽
Yasuhisa Koyanagi
Keyword(s):
Colorectal Cancer
◽
Cancer Patients
◽
Thymidine Phosphorylase
◽
P53 Gene
◽
Phosphorylase Activity
◽
Malignancy Grade
◽
Thymidine Phosphorylase Activity
◽
Colorectal Cancer Patients
Download Full-text
Abstract 937: Molecular analysis of KRAS exon 2 wild type colorectal cancer patients enrolled in the CAPRI clinical trial reveals high degree of tumor heterogeneity
10.1158/1538-7445.am2014-937
◽
2014
◽
Author(s):
Anna Maria Rachiglio
◽
Matilde Lambiase
◽
Francesca Fenizia
◽
Claudia Esposito
◽
Cristin Roma
◽
...
Keyword(s):
Colorectal Cancer
◽
Clinical Trial
◽
Cancer Patients
◽
Molecular Analysis
◽
Tumor Heterogeneity
◽
Wild Type
◽
Exon 2
◽
Colorectal Cancer Patients
◽
High Degree
◽
Kras Exon
Download Full-text
Abstract 2619: Genetic landscape of KRAS-NRAS-BRAF-PIK3CA wild type metastatic colorectal cancer patients enrolled in the CAPRI clinical trial
10.1158/1538-7445.am2018-2619
◽
2018
◽
Cited By ~ 1
Author(s):
Anna Maria Rachiglio
◽
Matilde Lambiase
◽
Francesca Fenizia
◽
Alessia Iannaccone
◽
Cristin Roma
◽
...
Keyword(s):
Colorectal Cancer
◽
Clinical Trial
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Wild Type
◽
Genetic Landscape
◽
Colorectal Cancer Patients
Download Full-text
FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial
Annals of Oncology
◽
10.1093/annonc/mdz155.088
◽
2019
◽
Vol 30
◽
pp. iv23-iv24
◽
Cited By ~ 3
Author(s):
A. Fernández Montes
◽
N. Martinez Lago
◽
J. De la Cámara Gómez
◽
M. Covela Rúa
◽
A. Cousillas Castiñeiras
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Treatment Phase
◽
Line Treatment
◽
Second Line
◽
Wild Type
◽
First Line
◽
Colorectal Cancer Patients
Download Full-text
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
British Journal of Cancer
◽
10.1038/s41416-019-0537-z
◽
2019
◽
Vol 121
(5)
◽
pp. 378-383
◽
Cited By ~ 1
Author(s):
Elena Elez
◽
Carles Pericay
◽
Manuel Valladares-Ayerbes
◽
Inmaculada Bando
◽
Maria Jose Safont
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Salvage Therapy
◽
Phase 2
◽
Wild Type
◽
Exon 2
◽
Phase 2 Study
◽
Colorectal Cancer Patients
◽
Kras Exon
Download Full-text
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
Cancer Communications
◽
10.1186/s40880-019-0374-8
◽
2019
◽
Vol 39
(1)
◽
pp. 28
◽
Cited By ~ 1
Author(s):
Yuankai Shi
◽
Jin Li
◽
Jianming Xu
◽
Yan Sun
◽
Liwei Wang
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Phase Iii
◽
Line Treatment
◽
Second Line
◽
Wild Type
◽
Open Label
◽
Phase Iii Trial
◽
Colorectal Cancer Patients
Download Full-text
397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
Annals of Oncology
◽
10.1016/j.annonc.2020.08.508
◽
2020
◽
Vol 31
◽
pp. S409-S410
Author(s):
E. Martinelli
◽
G. Martini
◽
T. Troiani
◽
F. Pietrantonio
◽
A. Avallone
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Wild Type
◽
Colorectal Cancer Patients
Download Full-text
P-78 Early tumour shrinkage, depth of response and survival outcomes for RAS wild-type metastatic colorectal cancer patients classified by baseline tumour load: Retrospective pooled analysis of panitumumab PRIME/PEAK studies
Annals of Oncology
◽
10.1016/j.annonc.2020.04.160
◽
2020
◽
Vol 31
◽
pp. S114-S115
Author(s):
F. Loupakis
◽
M. Peeters
◽
M. Geissler
◽
D. Modest
◽
M. Valladares-Ayerbes
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Pooled Analysis
◽
Survival Outcomes
◽
Wild Type
◽
Depth Of Response
◽
Tumour Load
◽
Tumour Shrinkage
◽
Colorectal Cancer Patients
Download Full-text
A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-016-3111-x
◽
2016
◽
Vol 78
(3)
◽
pp. 567-575
◽
Cited By ~ 1
Author(s):
Naoki Takahashi
◽
Satoru Iwasa
◽
Masaru Fukahori
◽
Kazuki Sudo
◽
Yusuke Sasaki
◽
...
Keyword(s):
Colorectal Cancer
◽
Phase I
◽
Cancer Patients
◽
Phase I Study
◽
Wild Type
◽
Previously Treated
◽
Colorectal Cancer Patients
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close